Data News > Class Action Lawsuit Filed Against Caribou Biosciences, Inc. (CRBU)
- Levi & Korsinsky, Bronstein, Gewirtz & Grossman, and Pomerantz Law Firm notify shareholders of a class action lawsuit against Caribou Biosciences, Inc. (CRBU).
- The lawsuit alleges violations of federal securities laws by the company and certain officers.
- Investors who suffered losses between July 14, 2023, and July 16, 2024, are encouraged to join the class action.
- The class action lawsuit aims to recover damages on behalf of affected shareholders.
- The deadline to join the lawsuit is February 24, 2025.
Levi & Korsinsky, Bronstein, Gewirtz & Grossman, and Pomerantz Law Firm have alerted shareholders of Caribou Biosciences, Inc. (CRBU) about a class action lawsuit filed against the company. The lawsuit, alleging violations of federal securities laws by Caribou and certain officers, aims to recover damages on behalf of all persons and entities who purchased or acquired Caribou securities between July 14, 2023, and July 16, 2024.
Investors who suffered losses on their Caribou Biosciences, Inc. investment within the specified dates are encouraged to join the class action lawsuit. The lawsuit, filed in the United States District Court for the Northern District of California, seeks to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 against the company and some of its top officials.
The deadline for investors to join the class action lawsuit is February 24, 2025. Shareholders who wish to learn more about the potential recovery under federal securities laws can visit the provided link or contact Joseph E. Levi, Esq. The lawsuit aims to address damages caused by alleged violations of federal securities laws by Caribou Biosciences, Inc. and certain officers during the specified Class Period.
Overall, shareholders who suffered losses on their Caribou Biosciences, Inc. investment have an opportunity to participate in the class action lawsuit and seek remedies under federal securities laws. It is crucial for affected investors to take action before the upcoming deadline to potentially recover their losses.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Class Action Lawsuit Filed Against Caribou Biosciences, Inc. (CRBU)
By KlickAnalytics Data Insights | December 31, 2024 08:02PM ET
Key Points
- Levi & Korsinsky, Bronstein, Gewirtz & Grossman, and Pomerantz Law Firm notify shareholders of a class action lawsuit against Caribou Biosciences, Inc. (CRBU).
- The lawsuit alleges violations of federal securities laws by the company and certain officers.
- Investors who suffered losses between July 14, 2023, and July 16, 2024, are encouraged to join the class action.
- The class action lawsuit aims to recover damages on behalf of affected shareholders.
- The deadline to join the lawsuit is February 24, 2025.
Levi & Korsinsky, Bronstein, Gewirtz & Grossman, and Pomerantz Law Firm have alerted shareholders of Caribou Biosciences, Inc. (CRBU) about a class action lawsuit filed against the company. The lawsuit, alleging violations of federal securities laws by Caribou and certain officers, aims to recover damages on behalf of all persons and entities who purchased or acquired Caribou securities between July 14, 2023, and July 16, 2024.
Investors who suffered losses on their Caribou Biosciences, Inc. investment within the specified dates are encouraged to join the class action lawsuit. The lawsuit, filed in the United States District Court for the Northern District of California, seeks to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 against the company and some of its top officials.
The deadline for investors to join the class action lawsuit is February 24, 2025. Shareholders who wish to learn more about the potential recovery under federal securities laws can visit the provided link or contact Joseph E. Levi, Esq. The lawsuit aims to address damages caused by alleged violations of federal securities laws by Caribou Biosciences, Inc. and certain officers during the specified Class Period.
Overall, shareholders who suffered losses on their Caribou Biosciences, Inc. investment have an opportunity to participate in the class action lawsuit and seek remedies under federal securities laws. It is crucial for affected investors to take action before the upcoming deadline to potentially recover their losses.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.